Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors

E-ISSN： 1873-4294|12|20|2240-2257

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.20, 2012-10, pp. : 2240-2257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyrazoline: A Promising Scaffold for the Inhibition of Monoamine Oxidase

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 195-206

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase Inhibition and Molecular Modeling Studies of Piperidyl-thienyl and 2-Pyrazoline Derivatives of Chalcones

Medicinal Chemistry, Vol. 11, Iss. 5, 2015-01 ,pp. : 497-505

Bentham Science Publishers

Access to resources Recommend Favorite

The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents

Current Medicinal Chemistry, Vol. 18, Iss. 33, 2011-11 ,pp. : 5114-5144

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine oxidase A and B inhibitors

By Jegham S. George P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1143-1150

Informa Healthcare

Access to resources Recommend Favorite

Focusing on new monoamine oxidase inhibitors

By Bolasco Adriana Carradori Simone Fioravanti Rossella

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 7, 2010-07 ,pp. : 909-939

Informa Healthcare

Access to resources Recommend Favorite